Document Detail


Nitric oxide synthase inhibition attenuates cutaneous vasodilation during postmenopausal hot flash episodes.
MedLine Citation:
PMID:  20505548     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The purpose of this study was to test the hypothesis that local inhibition of nitric oxide and prostaglandin synthesis attenuates cutaneous vasodilator responses during postmenopausal hot flash episodes.
METHODS: Four microdialysis membranes were inserted into the forearm skin (dorsal surface) of eight postmenopausal women (mean +/- SD age, 51 +/- 7 y). Ringer solution (control), 10 mM ketorolac (Keto) to inhibit prostaglandin synthesis, 10 mM N-l-arginine methyl ester (l-NAME) to inhibit nitric oxide synthase, and a combination of 10 mM Keto + 10 mM l-NAME were each infused at the separate sites. Skin blood flow at each site was indexed using laser-Doppler flowmetry. Cutaneous vascular conductance (CVC) was calculated as laser-Doppler flux/mean arterial blood pressure and was expressed as a percentage of the maximal calculated CVC (CVCmax) obtained after infusion of 50 mM sodium nitroprusside at all sites at the end of the study. Data from 13 hot flash episodes were analyzed.
RESULTS: At the control site, the mean +/- SD peak increase in CVC was 15.5% +/- 6% CVCmax units. This value was not different relative to the peak increase in CVC at the Keto site (13.0% +/- 5% CVCmax units; P = 0.09). However, the peak increase in CVC during hot flash episodes were attenuated at the l-NAME and l-NAME + Keto sites (7.4% +/- 4% and 8.7% +/- 7% CVCmax units, respectively) relative to both the control and the Keto sites (P < 0.05 for both comparisons). There were no significant differences in the peak increases in sweat rate between any of the sites (P = 0.24).
CONCLUSIONS: These data demonstrate that the mechanism for cutaneous vasodilation during hot flash episodes has a nitric oxide component. Increases in CVC despite the inhibition of prostaglandin synthesis suggest that prostaglandins do not contribute to cutaneous vasodilation during hot flash episodes.
Authors:
Kimberly A Hubing; Jonathan E Wingo; R Matthew Brothers; Juan Del Coso; David A Low; Craig G Crandall
Related Documents :
1727638 - Reduction of prostaglandin h synthase compound ii by phenol and hydroquinone, and the e...
2572378 - In vitro inhibition of prostaglandin h synthase by compounds from the exocrine secretio...
10857788 - Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in...
3474238 - Hormonal influence on glycosaminoglycan synthesis in uterine connective tissue of term ...
9770208 - Synthesis and anticonvulsant activity of some 2-n-(phthalimido)-1-alkyl esters.
21874958 - Design and characterization of a two-stage human subject exposure chamber.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Menopause (New York, N.Y.)     Volume:  17     ISSN:  1530-0374     ISO Abbreviation:  Menopause     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-09-14     Completed Date:  2011-01-06     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  9433353     Medline TA:  Menopause     Country:  United States    
Other Details:
Languages:  eng     Pagination:  978-82     Citation Subset:  IM    
Affiliation:
Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, Dallas, TX 75231, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Hot Flashes / physiopathology*
Humans
Middle Aged
NG-Nitroarginine Methyl Ester / pharmacology
Nitric Oxide / physiology*
Nitric Oxide Synthase / antagonists & inhibitors
Postmenopause / physiology*
Prostaglandins / physiology
Vasodilation / physiology*
Grant Support
ID/Acronym/Agency:
AG030189/AG/NIA NIH HHS; R21 AG030189-01A1/AG/NIA NIH HHS; R21 AG030189-02/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Prostaglandins; 10102-43-9/Nitric Oxide; 50903-99-6/NG-Nitroarginine Methyl Ester; EC 1.14.13.39/Nitric Oxide Synthase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initi...
Next Document:  Fetal brain during a binge drinking episode: a dynamic susceptibility contrast MRI fetal brain perfu...